Pharmacogenetics and anaesthetic drugs: Implications for perioperative practice

被引:19
作者
Behrooz, Arash [1 ]
机构
[1] Warwick Med Sch, Med Teaching Ctr, Coventry CV4 7AL, W Midlands, England
来源
ANNALS OF MEDICINE AND SURGERY | 2015年 / 4卷 / 04期
关键词
Anaesthetics; Pharmacogenetics; Perioperative medicine;
D O I
10.1016/j.amsu.2015.11.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pharmacogenetics seeks to elucidate the variations in individual's genetic sequences in order to better understand the differences seen in pharmacokinetics, drug metabolism, and efficacy between patients. This area of research is rapidly accelerating, aided by the use of novel and more economical molecular technologies. A substantial evidence base is being generated with the hopes that in the future it may be used to generate personalised treatment regimens in order to improve patient comfort and safety and reduce incidences of morbidity and mortality. Anaesthetics is an area of particular interest in this field, with previous research leading to better informed practice, specifically with regards to pseudocholinesterase deficiency and malignant hyperthermia. In this review, recent pharmacogenetic data pertaining to anaesthetic drugs will be presented and possible future applications and implications for practice will be discussed. (C) 2015 The Author. Published by Elsevier Ltd on behalf of IJS Publishing Group Limited.
引用
收藏
页码:470 / 474
页数:5
相关论文
共 47 条
  • [41] van der Weide Jan, 2006, Clin Biochem Rev, V27, P17
  • [42] Walker I., 2011, OXFORD HDB ANAESTHES, P4
  • [43] Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8
  • [44] Research Progress on the Role of ABC Transporters in the Drug Resistance Mechanism of Intractable Epilepsy
    Xiong, Jie
    Mao, Ding-an
    Liu, Li-qun
    [J]. BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [45] Induction of phase I, II and III drug metabolism/transport by xenobiotics
    Xu, CJ
    Li, CYT
    Kong, ANT
    [J]. ARCHIVES OF PHARMACAL RESEARCH, 2005, 28 (03) : 249 - 268
  • [46] Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
    Zanger, Ulrich M.
    Schwab, Matthias
    [J]. PHARMACOLOGY & THERAPEUTICS, 2013, 138 (01) : 103 - 141
  • [47] Asthma: Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic receptor gene as risk factors
    Zimiani de Paiva, Ana Carolina
    de Lima Marson, Fernando Augusto
    Ribeiro, Jose Dirceu
    Bertuzzo, Carmen Silvia
    [J]. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2014, 10